Isentress (Raltegravir)
| Brand Name: |
Isentress |
| Generic Name: |
Raltegravir, MK-0518 |
| Adult Single Dose: |
One 400-mg tablet twice daily |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
Integrase Inhibitor |
|
|
|
The Basics
- Raltegravir (Isentress) (January 13, 2012)
To read PDF, click here.
From AIDS InfoNet
- Merck Lowers Price of Isentress Drug for State AIDS Programs (January 12, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Says Merck's HIV Drug Gets Generic Threat (January 11, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- An Overview of Isentress (Raltegravir, MK-0518) (December 27, 2011)
From AIDSinfo
- Isentress (Raltegravir): Pediatric Dosing Recommendations and 2 Chewable Tablet Formulations for Pediatric Dosing (December 21, 2011)
From U.S. Food and Drug Administration
 Isentress (Raltegravir) Package Insert Updated (November 3, 2011)
From U.S. Food and Drug Administration
- Patient Information About Isentress (Raltegravir, MK-0518) (PDF) (November 2011)
Prescribing information.
From Merck & Co., Inc.
- Isentress (Raltegravir, MK-0518) Patient Product Information (PDF) (November 2011)
Patient information leaflet.
From Merck & Co., Inc.
- Characteristics of Integrase Inhibitor, Fusion Inhibitor and CCR5 Antagonist (PDF) (January 10, 2011)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Merck Announces Expanded Co-Pay Assistance Program for Isentress (Raltegravir) (October 22, 2010)
Enhanced program provides assistance to people living with HIV-1 who are privately insured and have out-of-pocket co-pays.
From Merck & Co., Inc.
- Details of Merck's ADAP Pricing Agreement: Isentress, Crixivan Costs Affected (May 5, 2010)
Price freeze of Isentress (Raltegravir) tablets for ADAPs through 2013 and acceleration of rebate payments to states among important initiatives highlighted.
From National Alliance of State and Territorial AIDS Directors
- AIDS Healthcare Foundation Keeps Up Pressure in Protests Against Merck's HIV Pricing (April 8, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Isentress (March/April 2010)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FDA Approves Expanded Use of HIV Drug (July 10, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- HIV/AIDS Update: Isentress (Raltegravir) Indication Extended for the Treatment of HIV-1 Infection in Treatment-Naive Patients (July 9, 2009)
From U.S. Food and Drug Administration
- HIV/AIDS Update: Traditional Approval of Isentress (raltegravir) (February 5, 2009)
From U.S. Food and Drug Administration
- Comparing Two Integrase Inhibitors (September/October 2008)
The first head-to-head study comparing raltegravir and elvitegravir.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Letter Sent by Merck to the Fair Pricing Coalition Announcing ADAP Price Freeze of Isentress (PDF) (August 1, 2008)
From Merck & Co., Inc.
- Isentress (Raltegravir) (January 8, 2008)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Mr. Sharp Goes to Washington (November/December 2007)
Advocating for a new drug before the FDA.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- How Isentress Works: An Interview With David Wohl, M.D. (Part II) (October 23, 2007)
A detailed look at how Isentress works.
From The Body
- The Bottom Line on Isentress: An Interview With David Wohl, M.D. (Part I) (October 23, 2007)
An overview of Isentress.
From The Body
- Project Inform Reacts to Approval, Pricing of Isentress (October 15, 2007)
From Project Inform
- FDA Approval of Isentress (Raltegravir) (October 12, 2007)
From U.S. Food and Drug Administration
- Isentress (Raltegravir) Pricing: Community Sign-On Letter (October 11, 2007)
In AIDS Treatment News, from AIDS Treatment News
|
Advertisement
|
Email
Glossary
